Cargando…

Planning for the Effect of the SC.24 Trial on Spine Stereotactic Body Radiation Therapy Utilization at a Tertiary Cancer Center

PURPOSE: The goal of this study was to assess the potential real-world effect of the recently reported SC.24 trial on spine stereotactic body radiation therapy (SBRT) utilization. We estimated the proportion of patients treated with conventional radiation therapy (CRT) who would have been eligible f...

Descripción completa

Detalles Bibliográficos
Autores principales: Arifin, Andrew J., Young, Sympascho, Bauman, Glenn S., Fakir, Hatim, Ahmad, Belal, Laba, Joanna M., Rodrigues, George B., Nguyen, Eric K., Sahgal, Arjun, Nguyen, Timothy K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10130065/
https://www.ncbi.nlm.nih.gov/pubmed/37124027
http://dx.doi.org/10.1016/j.adro.2023.101220
_version_ 1785030890116612096
author Arifin, Andrew J.
Young, Sympascho
Bauman, Glenn S.
Fakir, Hatim
Ahmad, Belal
Laba, Joanna M.
Rodrigues, George B.
Nguyen, Eric K.
Sahgal, Arjun
Nguyen, Timothy K.
author_facet Arifin, Andrew J.
Young, Sympascho
Bauman, Glenn S.
Fakir, Hatim
Ahmad, Belal
Laba, Joanna M.
Rodrigues, George B.
Nguyen, Eric K.
Sahgal, Arjun
Nguyen, Timothy K.
author_sort Arifin, Andrew J.
collection PubMed
description PURPOSE: The goal of this study was to assess the potential real-world effect of the recently reported SC.24 trial on spine stereotactic body radiation therapy (SBRT) utilization. We estimated the proportion of patients treated with conventional radiation therapy (CRT) who would have been eligible for spine SBRT per trial inclusion criteria and analyzed the potential estimated increased costs to our institution. METHODS AND MATERIALS: This was a retrospective review of patients who received spine CRT at our institution between August and October 2020. Data abstracted included demographics, SC.24 eligibility criteria, provider-reported pain response, and survival. A cost analysis and time survey was performed using institutional and provincial data. RESULTS: Of 73 patients reviewed, 24 patients (33%) were eligible. The most common exclusion factors included irradiation of ≥3 consecutive spinal segments (n = 32, 44%), Eastern Cooperative Oncology Group performance status >2 (n = 17, 23%), and symptomatic spinal cord compression (n = 13, 18%). Of eligible patients, the mean age was 68.92 years, median spinal instability in neoplasia score was 8 (interquartile range, 7-9), and median Eastern Cooperative Oncology Group performance status was 2 (interquartile range, 1-2). The most common primary cancer types among eligible patients were lung (n = 10) and breast (n = 4). The median survival of eligible patients was 10 months (95% confidence interval, 4 months to not reached) with 58% surviving longer than 3 months. Of patients who had subjective pain documented after CRT, 54% had at least some response. The cost of spine SBRT was estimated at CA$4764.80 compared with $3589.10 for CRT, and tasks for spine SBRT took roughly 3 times as long as those for CRT. CONCLUSIONS: One-third of patients who received palliative spine CRT met eligibility criteria for SC.24. This possible expanded indication for spine SBRT can have a substantial effect on resource utilization. These data may be useful in guiding resource planning at institutions looking to commence a spine SBRT program.
format Online
Article
Text
id pubmed-10130065
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-101300652023-04-27 Planning for the Effect of the SC.24 Trial on Spine Stereotactic Body Radiation Therapy Utilization at a Tertiary Cancer Center Arifin, Andrew J. Young, Sympascho Bauman, Glenn S. Fakir, Hatim Ahmad, Belal Laba, Joanna M. Rodrigues, George B. Nguyen, Eric K. Sahgal, Arjun Nguyen, Timothy K. Adv Radiat Oncol Scientific Article PURPOSE: The goal of this study was to assess the potential real-world effect of the recently reported SC.24 trial on spine stereotactic body radiation therapy (SBRT) utilization. We estimated the proportion of patients treated with conventional radiation therapy (CRT) who would have been eligible for spine SBRT per trial inclusion criteria and analyzed the potential estimated increased costs to our institution. METHODS AND MATERIALS: This was a retrospective review of patients who received spine CRT at our institution between August and October 2020. Data abstracted included demographics, SC.24 eligibility criteria, provider-reported pain response, and survival. A cost analysis and time survey was performed using institutional and provincial data. RESULTS: Of 73 patients reviewed, 24 patients (33%) were eligible. The most common exclusion factors included irradiation of ≥3 consecutive spinal segments (n = 32, 44%), Eastern Cooperative Oncology Group performance status >2 (n = 17, 23%), and symptomatic spinal cord compression (n = 13, 18%). Of eligible patients, the mean age was 68.92 years, median spinal instability in neoplasia score was 8 (interquartile range, 7-9), and median Eastern Cooperative Oncology Group performance status was 2 (interquartile range, 1-2). The most common primary cancer types among eligible patients were lung (n = 10) and breast (n = 4). The median survival of eligible patients was 10 months (95% confidence interval, 4 months to not reached) with 58% surviving longer than 3 months. Of patients who had subjective pain documented after CRT, 54% had at least some response. The cost of spine SBRT was estimated at CA$4764.80 compared with $3589.10 for CRT, and tasks for spine SBRT took roughly 3 times as long as those for CRT. CONCLUSIONS: One-third of patients who received palliative spine CRT met eligibility criteria for SC.24. This possible expanded indication for spine SBRT can have a substantial effect on resource utilization. These data may be useful in guiding resource planning at institutions looking to commence a spine SBRT program. Elsevier 2023-03-17 /pmc/articles/PMC10130065/ /pubmed/37124027 http://dx.doi.org/10.1016/j.adro.2023.101220 Text en © 2023 The Authors https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Scientific Article
Arifin, Andrew J.
Young, Sympascho
Bauman, Glenn S.
Fakir, Hatim
Ahmad, Belal
Laba, Joanna M.
Rodrigues, George B.
Nguyen, Eric K.
Sahgal, Arjun
Nguyen, Timothy K.
Planning for the Effect of the SC.24 Trial on Spine Stereotactic Body Radiation Therapy Utilization at a Tertiary Cancer Center
title Planning for the Effect of the SC.24 Trial on Spine Stereotactic Body Radiation Therapy Utilization at a Tertiary Cancer Center
title_full Planning for the Effect of the SC.24 Trial on Spine Stereotactic Body Radiation Therapy Utilization at a Tertiary Cancer Center
title_fullStr Planning for the Effect of the SC.24 Trial on Spine Stereotactic Body Radiation Therapy Utilization at a Tertiary Cancer Center
title_full_unstemmed Planning for the Effect of the SC.24 Trial on Spine Stereotactic Body Radiation Therapy Utilization at a Tertiary Cancer Center
title_short Planning for the Effect of the SC.24 Trial on Spine Stereotactic Body Radiation Therapy Utilization at a Tertiary Cancer Center
title_sort planning for the effect of the sc.24 trial on spine stereotactic body radiation therapy utilization at a tertiary cancer center
topic Scientific Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10130065/
https://www.ncbi.nlm.nih.gov/pubmed/37124027
http://dx.doi.org/10.1016/j.adro.2023.101220
work_keys_str_mv AT arifinandrewj planningfortheeffectofthesc24trialonspinestereotacticbodyradiationtherapyutilizationatatertiarycancercenter
AT youngsympascho planningfortheeffectofthesc24trialonspinestereotacticbodyradiationtherapyutilizationatatertiarycancercenter
AT baumanglenns planningfortheeffectofthesc24trialonspinestereotacticbodyradiationtherapyutilizationatatertiarycancercenter
AT fakirhatim planningfortheeffectofthesc24trialonspinestereotacticbodyradiationtherapyutilizationatatertiarycancercenter
AT ahmadbelal planningfortheeffectofthesc24trialonspinestereotacticbodyradiationtherapyutilizationatatertiarycancercenter
AT labajoannam planningfortheeffectofthesc24trialonspinestereotacticbodyradiationtherapyutilizationatatertiarycancercenter
AT rodriguesgeorgeb planningfortheeffectofthesc24trialonspinestereotacticbodyradiationtherapyutilizationatatertiarycancercenter
AT nguyenerick planningfortheeffectofthesc24trialonspinestereotacticbodyradiationtherapyutilizationatatertiarycancercenter
AT sahgalarjun planningfortheeffectofthesc24trialonspinestereotacticbodyradiationtherapyutilizationatatertiarycancercenter
AT nguyentimothyk planningfortheeffectofthesc24trialonspinestereotacticbodyradiationtherapyutilizationatatertiarycancercenter